Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in subjects with advanced ovarian cancer: Exploratory analysis of phase III OVA-301 study
Monk, B.J., Ghatage, P., Parekh, T., Henitz, E., Knoblauch, R., Soto Matos-Pita, A., Nieto, A., Park, Y.C., Ricci, D., Poveda, A.Volume:
133
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2014.03.119
Date:
June, 2014
File:
PDF, 62 KB
english, 2014